Works matching DE "FIBROLAMELLAR hepatocellular carcinoma"


Results: 108
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1367450
    By:
    • Hackenbruch, Christopher;
    • Bauer, Jens;
    • Heitmann, Jonas S.;
    • Maringer, Yacine;
    • Nelde, Annika;
    • Denk, Monika;
    • Zieschang, Lisa;
    • Kammer, Christine;
    • Federmann, Birgit;
    • Jung, Susanne;
    • Martus, Peter;
    • Malek, Nisar P.;
    • Nikolaou, Konstantin;
    • Salih, Helmut R.;
    • Bitzer, Michael;
    • Walz, Juliane S.
    Publication type:
    Article
    41
    42

    The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33746-3
    By:
    • Bauer, Jens;
    • Köhler, Natalie;
    • Maringer, Yacine;
    • Bucher, Philip;
    • Bilich, Tatjana;
    • Zwick, Melissa;
    • Dicks, Severin;
    • Nelde, Annika;
    • Dubbelaar, Marissa;
    • Scheid, Jonas;
    • Wacker, Marcel;
    • Heitmann, Jonas S.;
    • Schroeder, Sarah;
    • Rieth, Jonas;
    • Denk, Monika;
    • Richter, Marion;
    • Klein, Reinhild;
    • Bonzheim, Irina;
    • Luibrand, Julia;
    • Holzer, Ursula
    Publication type:
    Article
    43
    44

    Probing a rare tumour type.

    Published in:
    Nature Reviews Cancer, 2014, v. 14, n. 4, p. 218, doi. 10.1038/nrc3714
    By:
    • Seton-Rogers, Sarah
    Publication type:
    Article
    45
    46
    47
    48

    Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 2, p. 459, doi. 10.1111/jgh.13148
    By:
    • Lee, Aimei;
    • Rode, Anthony;
    • Nicoll, Amanda;
    • Maczurek, Annette E;
    • Lim, Lucy;
    • Lim, Seok;
    • Angus, Peter;
    • Kronborg, Ian;
    • Arachchi, Niranjan;
    • Gorelik, Alexandra;
    • Liew, Danny;
    • Warner, Fiona J;
    • McCaughan, Geoffrey W;
    • McLennan, Susan V;
    • Shackel, Nicholas A
    Publication type:
    Article
    49
    50